Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR


Creative Commons License

LALOĞLU E. , ALAY H.

UPSALA JOURNAL OF MEDICAL SCIENCES, vol.127, no.1, 2022 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 127 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.48101/ujms.v127.8211
  • Title of Journal : UPSALA JOURNAL OF MEDICAL SCIENCES
  • Keywords: Biomarker, COVID-19, endocan, reverse transcription polymerase hange reaction, SARS-CoV-2, CELL SPECIFIC MOLECULE-1

Abstract

Background: Endothelial-specific molecule 1 (endocan) has emerged as an inflammatory biomarker in recent years. The purpose of this study was to investigate the diagnostic value of serum endocan levels in the prediction of COVID-19 disease among patients with a false-negative reverse transcription polymerase change reaction (RT-PCR) test, and also to determine its correlation with the clinical severity of the disease.